Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Supercharging your own immune cells to fight blood cancer

NCT ID NCT06904066

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 33 times

Summary

This early-phase study tests a personalized treatment for people with certain blood cancers, like leukemia. Researchers take a patient's own immune cells (T cells), modify them in a lab to recognize unique markers on their cancer cells, and then infuse them back. The goal is to see if this approach is safe and can shrink or control the cancer. About 86 adults aged 18-75 with specific blood cancers will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELOID LEUKEMIA, ACUTE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.